Therapeutic anti-HIV (vpr) compounds
OwnerCharles A. Nicolette, Bruce D. Walkerinventors
Life of this patent
Estimating the term…
Abstract
The present invention provides synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effect or cells raised in response to presentation of these epitopes. The invention further provides methods for inducing an immune response and administering immunotherapy to a subject by delivering the compositions of the invention.
Claims9
A composition comprising at least one immunogenic ligand, wherein said immunogenic ligand is individually characterized by an ability to elicit an immune response against the same native ligand, and wherein said immunogenic ligand is selected from FLYEQGMFV (SEQ ID NO:1);
- FLYEQGIFV (SEQ ID NO:3);
- FLKMWKDAV (SEQ ID NO:5);
- FLSWTLPRV (SEQ ID NO:7);
- FLGGHWGTV (SEQ ID NO:9);
- and FLWWFTSTV (SEQ ID NO:11).
Dependencies are inferred from the claim text.